Literature DB >> 17048267

Potential role of CARMA1 in CD40-induced splenic B cell proliferation and marginal zone B cell maturation.

Bhanu P Pappu1, Xin Lin.   

Abstract

NF-kappaB activation through B cell receptor (BCR) ligation is critical for B cell development, survival and antigen-mediated activation of B cells. CARD domain and MAGUK-domain containing protein-1 (CARMA1), recently identified adaptor molecule, has been shown to play an essential role in BCR-induced NF-kappaB activation. CARMA1-deficient B cells fail to proliferate upon BCR stimulation, leading to defective humoral responses. Surprisingly, CARMA1-deficient B cells are also defective in CD40-induced proliferation. The mechanisms responsible for CD40-induced proliferation defect have not yet been characterized. In this study, we show that signaling cascades activated by CD40 stimulation are largely unaffected in CARMA1-deficient B cells. Instead, we have found that the defective proliferation of CARMA1-deficient B cells is due to two events. First, CARMA1-deficient B cells show defective cell-cycle progression. Secondly, the numbers of marginal zone (MZ) B cells, which are the main responders upon CD40 stimulation, are greatly diminished in CARMA1-deficient mice. Since B cell maturation requires basal signaling through BCR and NF-kappaB activation, we propose that impaired BCR signaling in CARMA1-deficient mice leads to defective maturation of MZ B cell population, which in turn, contributes to impaired proliferation upon CD40 stimulation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17048267     DOI: 10.1002/eji.200535663

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  10 in total

Review 1.  Roles of the NF-kappaB pathway in lymphocyte development and function.

Authors:  Steve Gerondakis; Ulrich Siebenlist
Journal:  Cold Spring Harb Perspect Biol       Date:  2009-12-23       Impact factor: 10.005

Review 2.  The follicular versus marginal zone B lymphocyte cell fate decision.

Authors:  Shiv Pillai; Annaiah Cariappa
Journal:  Nat Rev Immunol       Date:  2009-11       Impact factor: 53.106

Review 3.  Regulation of NF-κB by the CARD proteins.

Authors:  Changying Jiang; Xin Lin
Journal:  Immunol Rev       Date:  2012-03       Impact factor: 12.988

4.  Differing Requirements for MALT1 Function in Peripheral B Cell Survival and Differentiation.

Authors:  Peishan Lee; Zilu Zhu; Janna Hachmann; Takuya Nojima; Daisuke Kitamura; Guy Salvesen; Robert C Rickert
Journal:  J Immunol       Date:  2016-12-28       Impact factor: 5.422

Review 5.  CARMA1-mediated NF-kappaB and JNK activation in lymphocytes.

Authors:  Marzenna Blonska; Xin Lin
Journal:  Immunol Rev       Date:  2009-03       Impact factor: 12.988

6.  IκB kinase β (IKBKB) mutations in lymphomas that constitutively activate canonical nuclear factor κB (NFκB) signaling.

Authors:  Xin Kai; Vasant Chellappa; Carlos Donado; Deepak Reyon; Yurie Sekigami; Dalya Ataca; Abner Louissaint; Hamid Mattoo; J Keith Joung; Shiv Pillai
Journal:  J Biol Chem       Date:  2014-08-08       Impact factor: 5.157

7.  The coding genome of splenic marginal zone lymphoma: activation of NOTCH2 and other pathways regulating marginal zone development.

Authors:  Davide Rossi; Vladimir Trifonov; Marco Fangazio; Alessio Bruscaggin; Silvia Rasi; Valeria Spina; Sara Monti; Tiziana Vaisitti; Francesca Arruga; Rosella Famà; Carmela Ciardullo; Mariangela Greco; Stefania Cresta; Daniela Piranda; Antony Holmes; Giulia Fabbri; Monica Messina; Andrea Rinaldi; Jiguang Wang; Claudio Agostinelli; Pier Paolo Piccaluga; Marco Lucioni; Fabrizio Tabbò; Roberto Serra; Silvia Franceschetti; Clara Deambrogi; Giulia Daniele; Valter Gattei; Roberto Marasca; Fabio Facchetti; Luca Arcaini; Giorgio Inghirami; Francesco Bertoni; Stefano A Pileri; Silvia Deaglio; Robin Foà; Riccardo Dalla-Favera; Laura Pasqualucci; Raul Rabadan; Gianluca Gaidano
Journal:  J Exp Med       Date:  2012-08-13       Impact factor: 14.307

8.  L-CBM signaling in lymphocyte development and function.

Authors:  Hiromitsu Hara; Eiichi Iizasa; Mako Nakaya; Hiroki Yoshida
Journal:  J Blood Med       Date:  2010-06-04

9.  LRRK1 is critical in the regulation of B-cell responses and CARMA1-dependent NF-κB activation.

Authors:  Keiko Morimoto; Yoshihiro Baba; Hisaaki Shinohara; Sujin Kang; Satoshi Nojima; Tetsuya Kimura; Daisuke Ito; Yuji Yoshida; Yohei Maeda; Hana Sarashina-Kida; Masayuki Nishide; Takashi Hosokawa; Yasuhiro Kato; Yoshitomo Hayama; Yuhei Kinehara; Tatsusada Okuno; Hyota Takamatsu; Toru Hirano; Yoshihito Shima; Masashi Narazaki; Tomohiro Kurosaki; Toshihiko Toyofuku; Atsushi Kumanogoh
Journal:  Sci Rep       Date:  2016-05-11       Impact factor: 4.379

Review 10.  The CBM-opathies-A Rapidly Expanding Spectrum of Human Inborn Errors of Immunity Caused by Mutations in the CARD11-BCL10-MALT1 Complex.

Authors:  Henry Y Lu; Bradly M Bauman; Swadhinya Arjunaraja; Batsukh Dorjbal; Joshua D Milner; Andrew L Snow; Stuart E Turvey
Journal:  Front Immunol       Date:  2018-09-19       Impact factor: 7.561

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.